Spyre presents clinical data on IBD antibody therapies

🌐 Investing.com (Cyprus) — 2026-10-18

Biotechnology company Spyre presented clinical data on antibody therapies being developed for inflammatory bowel disease. The article description provides no further details on the trial results or study stage.

Health Spyre inflammatory bowel disease IBD antibody therapy clinical data biotechnology

Read original source →

STAT+: Senate health committee schedules vote on FDA commissioner nominee Overton
STAT News Health — 2026-11-11
SANUWAVE Health, Inc. 2026 Q3 - Results - Earnings Call Presentation
Seeking Alpha — 2026-11-11
Campos confirma primeiro caso de mpox registrado em 2026
Globo — 2026-11-11
Kulumur PHC to get a new outpatient ward
The Hindu — 2026-11-11
From Glastonbury to the London marathon—event medicine doctors are in the dark over new regulation
BMJ News — 2026-11-11
Consultants’ strike in England is called off as union “pauses” action
BMJ News — 2026-11-11

Spyre presents clinical data on IBD antibody therapies

AI Summary

Related Articles

STAT+: Senate health committee schedules vote on FDA commissioner nominee Overton

SANUWAVE Health, Inc. 2026 Q3 - Results - Earnings Call Presentation

Campos confirma primeiro caso de mpox registrado em 2026

Kulumur PHC to get a new outpatient ward

From Glastonbury to the London marathon&#x2014;event medicine doctors are in the dark over new regulation

Consultants&#x2019; strike in England is called off as union &#x201C;pauses&#x201D; action

From Glastonbury to the London marathon—event medicine doctors are in the dark over new regulation

Consultants’ strike in England is called off as union “pauses” action